Compare BIRD & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIRD | PDSB |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | 10 |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2M | 29.6M |
| IPO Year | 2021 | 2015 |
| Metric | BIRD | PDSB |
|---|---|---|
| Price | $2.69 | $0.62 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $11.00 | $9.00 |
| AVG Volume (30 Days) | 138.1K | ★ 413.8K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 20.22 | ★ 28.16 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $152,466,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $30.99 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.15 | $0.51 |
| 52 Week High | $12.84 | $1.90 |
| Indicator | BIRD | PDSB |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 49.64 |
| Support Level | $2.45 | $0.62 |
| Resistance Level | $3.48 | $0.73 |
| Average True Range (ATR) | 0.30 | 0.07 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 35.42 | 56.23 |
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.